Vasopressin pharmacological properties

P Dreyfuss. Synthesis and some pharmacological properties of 8-e-hydroxy norleu-cine-vasopressin. J Med Chem 17 252-257, 1974. 

Matsuhisa, A., Taniguchi, N., Koshio, H., Yatsu, T., Tanaka, A. Nonpeptide arginine vasopressin antagonists for both VIA and V2 receptors synthesis and pharmacological properties of 4 -(l,4,5, 6-tetrahydroimidazo[4,5-d][l]benzazepine-6-carbonyl)benzanilide derivatives and 4 -(5,6-dihydro-4H-thiazolo[5,4-d][l]benzazepine-6-carbonyl)benzanilide derivative. Chem. Pharmaceut. Bull. 2000, 4S, 21-31. 

Uterine contractions and fetal heart rate should be monitored during oxytocin administration (SEDA-13, 1310) (1,2). There is no significant increase in uterine complications or in fetal morbidity or mortality in women with a previous cesarean section, although oxytocin-treated patients had a higher rate of failed trial of labor for reasons that are unclear (3). Oxytocin is structurally similar to vasopressin, and like the latter has water-retaining properties when used in pharmacological doses. 

---